dievini Hopp BioTech holding GmbH & Co. KG
Overview
An active investor in innovative biotechnology companies, focusing on therapeutics and diagnostics for life-threatening diseases. The firm holds investments in nine companies across Germany, Switzerland, and Italy, primarily developing diagnostics, therapeutics, and vaccines targeting serious conditions such as cancer, infections, and neurodegenerative disorders. Notably, dievini has been a shareholder of CureVac AG since 2005, currently holding approximately 41% of the company's common shares.
Investment Focus
- Innovative biotechnology companies developing diagnostics, therapeutics, and vaccines for serious diseases
Portfolio Companies
Reach dievini Hopp BioTech holding GmbH & Co. KG directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about dievini Hopp BioTech holding GmbH & Co. KG
What sectors does dievini Hopp BioTech holding GmbH & Co. KG invest in?
dievini Hopp BioTech holding GmbH & Co. KG invests in Healthcare and Biotechnology, and is based in Baden-Württemberg, Germany. dievini Hopp BioTech holding GmbH & Co. KG is listed as a venture capital in the ConnectSafely investor database.
What stage does dievini Hopp BioTech holding GmbH & Co. KG invest at?
dievini Hopp BioTech holding GmbH & Co. KG backs companies at Early Stage and Growth.
Which regions does dievini Hopp BioTech holding GmbH & Co. KG invest in?
dievini Hopp BioTech holding GmbH & Co. KG invests across Germany, Italy and Switzerland.
What companies has dievini Hopp BioTech holding GmbH & Co. KG invested in?
dievini Hopp BioTech holding GmbH & Co. KG's portfolio includes CureVac AG, Apogenix GmbH and Heidelberg Pharma AG.
Last updated · Source: ConnectSafely investor database
